Bromide

Bromide

SCHEMBL524276

Br.CCCCC(CC)C(N)(CC)CC

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
TDP1 Q9NUW8 1/20 0.41
CA2 P00918 6/20 0.37
CA1 P00915 4/20 0.37
FDPS P14324 1/20 0.36
DNM1 Q05193 3/20 0.35
TSHR P16473 2/20 0.34
CYP3A4 P08684 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
OPRM1 P35372 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL868015 0.97 ALDH1A1 (0.42) ALDH1A1TDP1CA2CA1FDPS
Water SCHEMBL3620213 0.95 ALDH1A1 (0.41) ALDH1A1TDP1CA2CA1FDPS
Iodide SCHEMBL5086947 0.95 ALDH1A1 (0.41) ALDH1A1TDP1CA2CA1FDPS
Hydrochloric Acid SCHEMBL5087173 0.95 ALDH1A1 (0.41) ALDH1A1TDP1CA2CA1FDPS
Bromide SCHEMBL5085383 0.93 OPRM1 (0.42) ALDH1A1TDP1FDPSDNM1TSHR
Bromide SCHEMBL5087965 0.91 FDPS (0.42) FDPSDNM1TSHRCYP3A4OPRM1
Bromide SCHEMBL5088644 0.91 FDPS (0.42) FDPSDNM1TSHRCYP3A4OPRM1
Bromide SCHEMBL1011285 0.91 FDPS (0.42) FDPSDNM1TSHRCYP3A4OPRM1
Bromide SCHEMBL5088172 0.91 FDPS (0.42) FDPSDNM1TSHRCYP3A4OPRM1
Bromide SCHEMBL5087875 0.91 FDPS (0.42) FDPSDNM1TSHRCYP3A4OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250387762-A1 MULTILAYER SOL-GEL GREEN CERAMIC MEMBRANE AND USES THEREOF PETROLEO BRASILEIRO S A PRETROBRAS (BR) 2025-12-25 US claimed
CN-119081437-A Artificial board based on soybean-based adhesive and agricultural waste and preparation method thereof 华南农业大学 2024-12-06 CN claimed
CN-117701243-B Organosilicon modified soybean flavone adhesive and preparation method and application thereof 华南农业大学 2024-06-14 CN claimed
CN-117701227-B Polymer modified soybean flavone adhesive and preparation method and application thereof 华南农业大学 2024-05-24 CN claimed
CN-117701243-A Organosilicon modified soybean flavone adhesive and preparation method and application thereof 华南农业大学 2024-03-15 CN claimed
CN-117701227-A Polymer modified soybean flavone adhesive and preparation method and application thereof 华南农业大学 2024-03-15 CN claimed
CN-116754760-B Method for coupling 2, 4-Dinitrophenol (DNP) with controlled cleavage of antibody 之江实验室 2024-01-26 CN claimed
CN-116754760-A Method for coupling 2, 4-Dinitrophenol (DNP) with controlled cleavage of antibody 之江实验室 2023-09-15 CN claimed
CN-113441178-B TiO 2 Application of SAPO-5 catalyst in preparation of cycloalkyl-substituted aromatic hydrocarbon by using low-carbon alkylating agent and method thereof 西北大学 2023-05-09 CN claimed
CN-115403734-A Dai blek-based polyester curing agent and preparation method thereof 安徽泓泽新材料科技有限公司 2022-11-29 CN claimed
US-7964110-B2 Cure system for halogenated elastomer compositions, a curable halogenated elastomer composition, and a method for curing halogenated elastomer compositions DOW GLOBAL TECHNOLOGIES LLC (US) 2011-06-21 US claimed
US-7745543-B2 Cure system composition and a method for curing chlorinated elastomer compositions DOW GLOBAL TECHNOLOGIES INC. (US) 2010-06-29 US claimed
US-7741409-B2 Cure system composition and a method for curing chlorinated elastomer compositions DOW GLOBAL TECHNOLOGIES INC. (US) 2010-06-22 US claimed
US-20100010152-A1 CURE SYSTEM OF HALOGENATED ELASTOMER COMPOSITIONS, A CURABLE HALOGENATED ELASTOMER COMPOSITION, AND A METHOD FOR CURING HALOGENATED ELASTOMER COMPOSITIONS DOW GLOBAL TECHNOLOGIES LLC 2010-01-14 US claimed
EP-1960462-B1 A CURE SYSTEM FOR HALOGENATED ELASTOMER COMPOSITIONS, A CURABLE HALOGENATED ELASTOMER COMPOSITION, AND A METHOD FOR CURING HALOGENATED ELASTROMER COMPOSITIONS DOW GLOBAL TECHNOLOGIES INC (US) 2010-01-13 EP claimed
US-20090326143-A1 CURE SYSTEM FOR HALOGENATED ELASTOMER COMPOSITIONS, A CURABLE HALOGENATED ELASTOMER COMPOSITION, AND A METHOD FOR CURING HALOGENATED ELASTOMER COMPOSITIONS DOW GLOBAL TECHNOLOGIES LLC 2009-12-31 US claimed
EP-2059557-A2 A CURE SYSTEM FOR HALOGENATED ELASTOMER COMPOSITIONS, A CURABLE HALOGENATED ELASTOMER COMPOSITION, AND A METHOD FOR CURING HALOGENATED ELASTOMER COMPOSITIONS Dow Global Technologies Inc. (US) 2009-05-20 EP claimed
EP-1960462-A1 A CURE SYSTEM FOR HALOGENATED ELASTOMER COMPOSITIONS, A CURABLE HALOGENATED ELASTOMER COMPOSITION, AND A METHOD FOR CURING HALOGENATED ELASTROMER COMPOSITIONS Dow Global Technologies Inc. (US) 2008-08-27 EP claimed
WO-2008027757-A1 A CURE SYSTEM FOR HALOGENATED ELASTOMER COMPOSITIONS, A CURABLE HALOGENATED ELASTOMER COMPOSITION, AND A METHOD FOR CURING HALOGENATED ELASTROMER COMPOSITIONS DOW GLOBAL TECHNOLOGIES INC. (US) 2008-03-06 WO claimed
WO-2008027754-A2 A CURE SYSTEM FOR HALOGENATED ELASTOMER COMPOSITIONS, A CURABLE HALOGENATED ELASTOMER COMPOSITION, AND A METHOD FOR CURING HALOGENATED ELASTOMER COMPOSITIONS DOW GLOBAL TECHNOLOGIES INC. (US) 2008-03-06 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250387762-A1 MULTILAYER SOL-GEL GREEN CERAMIC MEMBRANE AND USES THEREOF GK, CACNG2, COG2 ALDH1A1 2768/4885TDP1 4562/4885CA2 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.